Total trials
116
Active
27
Phase 3
3
Total enrollment
13,352
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Saline | — | — | — | — | — | 2 | |
| N-acetyl cysteine | — | — | — | — | — | 1 | |
| NAC | — | — | — | — | — | 1 |
Next readouts
- 2017-09
- 2018-01
Top conditions
- Stroke6
- Nursing Students4
- Periodontitis4
- Misadventure During Endoscopic Examination3
- Anxiety3
- Muscle Stretching Exercise2
- Stroke, Acute2
- Health Behavior2
Frequently asked questions about Suleyman Demirel University
- How many clinical trials does Suleyman Demirel University have on ClinicalTrials.gov?
- Suleyman Demirel University is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 27 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Suleyman Demirel University's trials are in Phase 3?
- 3 of Suleyman Demirel University's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Suleyman Demirel University focus on?
- Suleyman Demirel University's most-studied conditions on ClinicalTrials.gov are Stroke, Nursing Students, Periodontitis, Misadventure During Endoscopic Examination, Anxiety.
- When are Suleyman Demirel University's next clinical trial readouts?
- Suleyman Demirel University has 2 upcoming primary-completion readouts tracked here; the soonest is “Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention”, expected around 2017-09.